Moderna will carry out a placebo-controlled trial of its new COVID-19 vaccine, and the Food and Drug Administration will keep tabs on the trial, Health Secretary Robert F. Kennedy Jr. said on June 3.
“I want to address those of you who have anxieties about FDA’s limited approval of a new mRNA COVID vaccine for high-risk populations,” Kennedy wrote on social media platform X. “Moderna has agreed to a true placebo-controlled trial of the new vaccine.”
